Soleno Therapeutics, Inc.
SLNO
$65.56
$2.824.50%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -176.84% | -280.98% | -351.04% | -295.33% | -129.92% |
| Total Depreciation and Amortization | 2.34% | 2.20% | 1.48% | 0.82% | 0.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 437.69% | 648.84% | 977.81% | 984.38% | 471.51% |
| Change in Net Operating Assets | -16,223.53% | -147.91% | 105.53% | 590.13% | -113.23% |
| Cash from Operations | -96.79% | -190.57% | -177.05% | -116.33% | -93.84% |
| Capital Expenditure | -1,021.05% | -1,827.27% | -- | -3,400.00% | -216.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 110.89% | 24.25% | -- | -- | -- |
| Cash from Investing | 110.80% | 24.07% | -- | -3,868,650.00% | -3,935,983.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -90.96% | -8.55% | -9.38% | 395.07% | 1,719.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -75.29% | 18.98% | 18.33% | 395.07% | 1,719.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.29% | 10.04% | -152.72% | -112.31% | 901.70% |